- Moody's•yesterdayBoston Scientific Corporation -- Moody's upgrades Boston Scientific's senior unsecured rating to Baa2; outlook is stable
New York, December 07, 2016-- Moody's Investors Service today upgraded Boston Scientific Corporation's senior unsecured rating to Baa2 from Baa3. This action is based on Moody's expectation that Boston ...
- Investor's Business Daily•2 days ago
Edwards Lifesciences 2017 guidance could be somewhat strangled Thursday on Medtronic and Boston Scientific competition.
- Zacks•3 days ago
Boston Scientific Corporation (BSX) recently inked a deal with specialty medical device company Neovasc Inc.
BSX : Summary for Boston Scientific Corporation C - Yahoo Finance
Boston Scientific Corporation (BSX)
NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
|Bid||20.63 x 4900|
|Ask||20.64 x 1900|
|Day's Range||20.39 - 20.76|
|52 Week Range||15.67 - 24.79|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||388.30|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|